Desiree L Kunac

Summary

Affiliation: University of Otago
Country: New Zealand

Publications

  1. ncbi Preventable medication-related events in hospitalised children in New Zealand
    Desiree L Kunac
    School of Pharmacy, University of Otago, Dunedin, New Zealand
    N Z Med J 121:17-32. 2008
  2. ncbi Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study
    Desiree L Kunac
    School of Pharmacy, University of Otago, Dunedin, New Zealand
    Paediatr Drugs 11:153-60. 2009
  3. ncbi Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis
    Desiree L Kunac
    New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
    Drug Saf 34:59-71. 2011
  4. ncbi Identification of priorities for medication safety in neonatal intensive care
    Desiree L Kunac
    School of Pharmacy, University of Otago, Dunedin, New Zealand
    Drug Saf 28:251-61. 2005
  5. ncbi The Intensive Vaccines Monitoring Programme (IVMP): an electronic system to monitor vaccine safety in New Zealand
    Michael V Tatley
    New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand
    Vaccine 26:2746-52. 2008
  6. ncbi Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use
    Desiree L Kunac
    NZPhvC, Department of Preventive and Social Medicine, University of Otago, P O Box 913, Dunedin, New Zealand
    N Z Med J 121:76-89. 2008

Detail Information

Publications6

  1. ncbi Preventable medication-related events in hospitalised children in New Zealand
    Desiree L Kunac
    School of Pharmacy, University of Otago, Dunedin, New Zealand
    N Z Med J 121:17-32. 2008
    ..To evaluate the frequency and characteristics of preventable medication-related events in hospitalised children, to determine the yield of several methods for identifying them and to recommend priorities for prevention...
  2. ncbi Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study
    Desiree L Kunac
    School of Pharmacy, University of Otago, Dunedin, New Zealand
    Paediatr Drugs 11:153-60. 2009
    ..Over half of the ADEs were deemed preventable. This highlights the importance of developing strategies to prevent and ameliorate ADEs both to improve the quality of patient care and to reduce healthcare costs...
  3. ncbi Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis
    Desiree L Kunac
    New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
    Drug Saf 34:59-71. 2011
    ..Despite the traditional focus being adverse drug reactions (ADRs), pharmacovigilance centres have recently been identified as a potentially rich and important source of medication error data...
  4. ncbi Identification of priorities for medication safety in neonatal intensive care
    Desiree L Kunac
    School of Pharmacy, University of Otago, Dunedin, New Zealand
    Drug Saf 28:251-61. 2005
    ..The aim of this study was to identify and prioritize potential failures in the neonatal intensive care unit (NICU) medication use process through application of FMEA...
  5. ncbi The Intensive Vaccines Monitoring Programme (IVMP): an electronic system to monitor vaccine safety in New Zealand
    Michael V Tatley
    New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand
    Vaccine 26:2746-52. 2008
    ..We describe the methodology and success factors plus consider the limitations encountered in this system which shows potential as a means for post-marketing vaccine and medicine surveillance in the future...
  6. ncbi Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use
    Desiree L Kunac
    NZPhvC, Department of Preventive and Social Medicine, University of Otago, P O Box 913, Dunedin, New Zealand
    N Z Med J 121:76-89. 2008
    ..The NZPhvC operates three pharmacovigilance programmes and this article explains how each of these programmes operate, focuses on their strengths and limitations, and looks to the future for medicines safety monitoring in NZ...